These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5923255)

  • 21. Susceptibility of mice to experimental staphylococcal pyelonephritis after treatment with some antibacterial agents.
    Toivanen P; Toivanen A
    Bibl Microbiol; 1966; 5():38-45. PubMed ID: 5957403
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase.
    Aratani Y; Kura F; Watanabe H; Akagawa H; Takano Y; Suzuki K; Maeda N; Koyama H
    J Infect Dis; 2000 Oct; 182(4):1276-9. PubMed ID: 10979934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lung infections in immunodepressed patients].
    Jemni L; Hmouda H
    Tunis Med; 1994; 72(6-7):406-11. PubMed ID: 7871596
    [No Abstract]   [Full Text] [Related]  

  • 24. Biologic contaminants.
    Seltzer JM
    Occup Med; 1995; 10(1):1-25. PubMed ID: 7792669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of alcohol on immunity and bacterial infection in the lung.
    Gamble L; Mason CM; Nelson S
    Med Mal Infect; 2006 Feb; 36(2):72-7. PubMed ID: 16413723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of phagocyte lifespan in the lung during bacterial infection.
    Dockrell DH; Whyte MK
    J Leukoc Biol; 2006 May; 79(5):904-8. PubMed ID: 16478918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathogenesis of acute destructive lung processes of staphylococcal etiology].
    Muromskiĭ IuA; Egorkina DA; Savitskaia KI
    Vestn Khir Im I I Grek; 1981 Mar; 126(3):16-9. PubMed ID: 6894507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice.
    Wu H; Song Z; Hentzer M; Andersen JB; Molin S; Givskov M; Høiby N
    J Antimicrob Chemother; 2004 Jun; 53(6):1054-61. PubMed ID: 15117922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucan alteration of pulmonary antibacterial defense.
    Kimura A; Sherwood RL; Goldstein E
    J Reticuloendothel Soc; 1983 Jul; 34(1):1-11. PubMed ID: 6876030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Natural and experimental staphylococcal infections in ducks. Strain characteristics].
    Hummel R; Jung S; Eisengarten HJ
    Arch Exp Veterinarmed; 1982; 36(6):933-42. PubMed ID: 7168611
    [No Abstract]   [Full Text] [Related]  

  • 31. EXPERIMENTAL STAPHYLOCOCCAL INFECTION OF THE SUBCUTANEOUS TISSUE OF THE MOUSE. I. BACTERIAL POPULATION CHANGES IN RELATION TO TISSUE RESPONSE.
    FISHER S; ROBSON JE
    J Infect Dis; 1963; 113():204-12. PubMed ID: 14080830
    [No Abstract]   [Full Text] [Related]  

  • 32. Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection.
    Stark JM; Stark MA; Colasurdo GN; LeVine AM
    J Med Virol; 2006 Jun; 78(6):829-38. PubMed ID: 16628585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against mycoplasma infection using expression-library immunization.
    Barry MA; Lai WC; Johnston SA
    Nature; 1995 Oct; 377(6550):632-5. PubMed ID: 7566175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination by aerosols: modulation of clearance mechanisms in the lung.
    Hensel A; Lubitz W
    Behring Inst Mitt; 1997 Feb; (98):212-9. PubMed ID: 9382742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The cloning and expression of rhlR, a quorum sensing gene in Pseudomonas aeruginosa PAO1, and a study of its effect on bacterial clearance rate in mouse lung].
    Du BZ; Xie Y; Jia WX; Yang FL; Zeng W; Yang WQ; Cheng X; Chen T; Zhang ZR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):661-5. PubMed ID: 17037722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.
    Nilsson IM; Verdrengh M; Ulrich RG; Bavari S; Tarkowski A
    J Infect Dis; 1999 Oct; 180(4):1370-3. PubMed ID: 10479175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens.
    Davidson DJ; Dorin JR; McLachlan G; Ranaldi V; Lamb D; Doherty C; Govan J; Porteous DJ
    Nat Genet; 1995 Apr; 9(4):351-7. PubMed ID: 7540910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of mice to experimental staphylococcal pyelonephritis after treatment with mercaptomerin, hydrochlorothiazide or acetazolamide.
    Toivanen A; Toivanen P
    Bibl Microbiol; 1966; 5():32-7. PubMed ID: 5957402
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical assessment of localized forms of staphylococcal infection].
    Morgunov IN; Bordonos VG; Pavlenko VA
    Vrach Delo; 1982 Sep; (9):111-3. PubMed ID: 7179899
    [No Abstract]   [Full Text] [Related]  

  • 40. Importance of Staphylococcus aureus in allergy in a rural environment.
    Laborie F; Laborie R
    Allergol Immunopathol (Madr); 1980; 8(5):587-602. PubMed ID: 7468398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.